C10AX14 Alirocumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Alirocumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- C Cardiovascular system drugs 1,385 drugs
- C10 Lipid modifying agents 270 drugs
- C10A Lipid modifying agents, plain 264 drugs
- C10AX Other lipid modifying agents 34 drugs
- C10AX14 Alirocumab 2 drugs
- C10AX Other lipid modifying agents 34 drugs
- C10A Lipid modifying agents, plain 264 drugs
- C10 Lipid modifying agents 270 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Praluent (Sanofi-Aventis Canada, 75 mg, 150 mg, 300 mg) PM | prescription (Rx) |
| Praluent (Sanofi-Aventis Canada, 75 mg, 150 mg) PM | prescription (Rx) |
Other classes of the same level
- C10AX06 Omega-3-triglycerides incl. other esters and acids 1 drug
- C10AX09 Ezetimibe 27 drugs
- C10AX12 Lomitapide 1 drug
- C10AX15 Bempedoic acid 1 drug
- C10AX16 Inclisiran 1 drug
- C10AX17 Evinacumab 1 drug
Other names of the drug class
- Czech: C10AX14 Alirokumab
- English (United Kingdom): C10AX14 alirocumab
- German: C10AX14 Alirocumab
- Spanish: C10AX14 Alirocumab
- German (Austria): C10AX14 Alirocumab
- Italian: C10AX14 ALIROCUMAB
- Turkish: C10AX14 alirocumab
- Portuguese (Brazil): C10AX14 Alirocumab
- German (Switzerland): C10AX14 Alirocumab
- French (Switzerland): C10AX14 Alirocumab
- Italian (Switzerland): C10AX14 Alirocumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class C10AX14
Ask your doctor or pharmacist for advice.